MedTrace Logo

Development and Validation of a Scale of Propensity for Change in Chronic Disease Prevention

NCT07765797 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 290

Last updated 2026-08-14

No results posted yet for this study

Summary

Modifiable risk factors are estimated to account for 70% of cardiovascular diseases, 40% of Alzheimer's-type dementias, and 50% of type 2 diabetes cases. Numerous trials have evaluated interventions aimed at modifying these risk factors, whether through the promotion of healthy lifestyle choices (diet, physical activity, etc.) or specific activities (cognitive training, etc.). However, these trials have yielded inconsistent or modest results, potentially due to a failure to adopt the recommended lifestyle changes. To better tailor prevention interventions, it is therefore essential to have scales available that measure the barriers to and facilitators of lifestyle change.

The aim of this study is to develop and validate a Patient-Reported Outcome Measure (PROM) to assess the barriers to and facilitators of change following participation in a prevention program. The scale will be structured into three sub-scales (capability, opportunity, and motivation), administered one month after the prevention activity, and will distinguish between the adoption of new habits and the abandonment of existing ones.

Conditions

  • Atheroscleroses
  • Geriatric

Interventions

OTHER

Scale development phase

Questionnaire administered to patients to develop the scale's items and group them into subscales.

OTHER

Beta testing phase

The scale will be administered to the patient in the form of a questionnaire for the testing phase.

OTHER

Validation phase

The scale will be administered to patients in the form of questionnaires for the validation phase.

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2028-03-01
Completion
2028-06-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07765797 on ClinicalTrials.gov